Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Chinese Journal of Cancer Research
Published in: Chinese Journal of Cancer Research 4/2011

01-12-2011 | Original Article

Prognostic value of promoter hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in prostate cancer

Authors: A. Ameri, A. Alidoosti, Y. Hosseini, M. Parvin, M. H. Emranpour, F. Taslimi, E. Salehi, P. Fadavi

Published in: Chinese Journal of Cancer Research | Issue 4/2011

Login to get access
Metadata
Title
Prognostic value of promoter hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in prostate cancer
Authors
A. Ameri
A. Alidoosti
Y. Hosseini
M. Parvin
M. H. Emranpour
F. Taslimi
E. Salehi
P. Fadavi
Publication date
01-12-2011
Publisher
Chinese Anti-Cancer Association
Published in
Chinese Journal of Cancer Research / Issue 4/2011
Print ISSN: 1000-9604
Electronic ISSN: 1993-0631
DOI
https://doi.org/10.1007/s11670-011-0306-x

Other articles of this Issue 4/2011

Chinese Journal of Cancer Research 4/2011 Go to the issue

Original Article

Mast cells in adjacent normal colon mucosa rather than those in invasive margin are related to progression of colon cancer

Original Article

Expression and distribution characteristics of human ortholog of mammalian enabled (hMena) in glioma

Erratum

Erratum to: Diagnostic value of mini-laparoscopy in patients with abdominal neoplasm

Erratum

Erratum to: Src Is dephosphorylated at tyrosine 530 in human colon carcinomas

Review

Hepatocellular tumors: Immunohistochemical analyses for classification and prognostication

Original Article

Expressions of thymidylate synthase, thymidine phosphorylase, class III β-tubulin, and excision repair cross-complementing group 1 predict response in advanced gastric cancer patients receiving capecitabine plus paclitaxel or cisplatin
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits